19th March 2026, Thursday

TechPharus

Latest Posts

HealthTech News

  • UK meningitis outbreak cases rise to 27: official
    on March 19, 2026 at 6:10 pm

    The number of meningitis cases being probed by UK authorities has risen to 27, health officials said Thursday, following an unprecedented deadly outbreak centered on a university.

  • Smart wound dressing delivers antibiotics on-demand, accelerating healing and reducing resistance
    on March 19, 2026 at 6:00 pm

    Biomedical engineers from Brown University have developed a new wound dressing material that releases antibiotic drugs only when harmful bacteria are present in a wound. In the new study, published in the journal Science Advances, the researchers show that the material could help rapidly clear wound infections to accelerate healing while reducing the unnecessary use of antibiotics—a major driver of antibiotic resistance and hard-to-treat “superbug” infections that claim tens of thousands of lives worldwide each year.

  • Why chronic pain leads to depression for some but not others
    on March 19, 2026 at 6:00 pm

    Scientists have uncovered a brain mechanism that may explain why chronic pain leads to depression in some people but not others, according to research published in Science. The findings challenge the idea that depression is an inevitable consequence of long-term pain.

  • How an imbalanced gut microbiome worsens chronic kidney disease
    on March 19, 2026 at 6:00 pm

    Researchers at UC Davis School of Medicine have uncovered how an imbalanced gut microbiome escalates the production of metabolic byproducts by certain gut bacteria. This imbalance drives a feedback loop that worsens chronic kidney disease (CKD) in mice. The scientists identified an investigational drug that might break the destructive cycle. The findings are published in Science.

  • New ‘fishhook’ bonds help T cells stick longer to prostate cancer cells
    on March 19, 2026 at 6:00 pm

    UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new class of supercharged T cells that are stronger, longer-lasting, and more precise at killing prostate cancer cells by fine-tuning how they physically interact with tumor cells.